Inclusion Criteria:  Age ≥18 years. Histologically confirmed invasive breast carcinoma Clinical stage II-III at presentation Scheduled for neoadjuvant chemotherapy Signed informed consent Eastern Cooperative Oncology Group (ECOG) performance status of 0-1  Exclusion Criteria:  Patients who have received any prior chemotherapy, radiation therapy or endocrine therapy for their current breast cancer. Patients with any general contraindication to MRI. Patient with breast cancer who are not eligible for NAC (pregnant patients, multicentric breast cancer, metastatic breast cancer).